---
title: "MREO: Late-stage rare disease programs near regulatory milestones, with major updates due in the next quarter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298623061.md"
description: "Three rare disease programs are advancing with strong partnerships, late-stage data, and regulatory engagement. Alvelestat and setrusumab are both approaching key regulatory milestones, with significant market and royalty potential, and updates expected by year-end.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-10T16:20:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298623061.md)
  - [en](https://longbridge.com/en/news/298623061.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298623061.md)
generator: "portal-rs"
---

# MREO: Late-stage rare disease programs near regulatory milestones, with major updates due in the next quarter

Three rare disease programs are advancing with strong partnerships, late-stage data, and regulatory engagement. Alvelestat and setrusumab are both approaching key regulatory milestones, with significant market and royalty potential, and updates expected by year-end.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MREO.US](https://longbridge.com/en/quote/MREO.US.md)

## Related News & Research

- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [What Elevance Health Holders Got Right](https://longbridge.com/en/news/306380588.md)
- [CrowdStrike (CRWD) in Talks to Buy Zscaler (ZS), Sending Shares in Opposite Directions](https://longbridge.com/en/news/306394450.md)
- [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md)
- [Amazon (AMZN) Eyes $7.5 Billion AI Startup Deal as Nvidia Rivalry Heats Up](https://longbridge.com/en/news/306393125.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**